BioMarin to Participate in Two Upcoming Virtual Investor Conferences

Rhea-AI Summary

BioMarin Pharmaceutical (NASDAQ: BMRN) has announced its participation in two upcoming virtual investor conferences. An audio webcast of these presentations will be available live, with access provided through the company's investor relations website. Additionally, an archived version will be accessible for a limited time post-conference. BioMarin specializes in innovative therapies for serious rare disorders, boasting a portfolio of six commercialized products along with several candidates in clinical stages.

News Market Reaction – BMRN

-0.46%

-0.46% Session move

In the trading session that priced this news, BMRN declined 0.46%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SAN RAFAEL, Calif., Jan. 5, 2021 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will participate in two upcoming virtual conferences.  An audio webcast of the presentations will be available live. You can access the webcast at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference.

About BioMarin

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates.  

For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.

Contacts:
Investors	Media
Traci McCarty	Debra Charlesworth
BioMarin Pharmaceutical Inc.	BioMarin Pharmaceutical Inc.
(415) 455-7558	(415) 455-7451

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/biomarin-to-participate-in-two-upcoming-virtual-investor-conferences-301200463.html

SOURCE BioMarin Pharmaceutical Inc.

FAQ

What conferences will BioMarin participate in January 2021?

BioMarin will participate in two virtual investor conferences in January 2021.

How can I access BioMarin's conference webcasts?

You can access the live audio webcasts of the presentations through BioMarin's investor relations website.

Where can I find archived presentations from BioMarin's investor conferences?

Archived versions of BioMarin's presentations will be available on their website for a limited time after the conferences.

What is BioMarin Pharmaceutical's core focus?

BioMarin specializes in developing innovative therapies for people with serious and life-threatening rare disorders.

What stock symbol represents BioMarin Pharmaceutical?

BioMarin Pharmaceutical trades under the stock symbol 'BMRN'.